Case Study

Sanofi Leverages SAP Access Control to Help Secure SAP S/4HANA Migration During COVID-19 Vaccine Response

Sanofi Leverages SAP Access Control to Help Secure SAP S/4HANA Migration During COVID-19 Vaccine Response

Pages 3 Pages

Member Insights MEMBER SAPinsider SAPinsider Sanofi Leverages SAP Access Control to Help Secure SAP S/4HANA Migration During COVID-19 Vaccine Response French pharmaceuticals maker streamlines thousands of new business roles as part of global user access management system update As the COVID-19 pandemic raged across the world in 2020, French pharmaceuticals maker Sanofi was one of the companies working to develop vaccines for the highly contagious disease. At the same time, Sanofi was working with Accenture and KPMG to migrate from SAP ERP Central Component System to SAP S/4HANA and consolidate and optimize its IT environment. This was an ambitious undertaking considering the unique economic environment, the firm’s multinational reach, and the heavily regulated nature of th

Join for free to read